Global leukemia market is expected to grow significantly at a CAGR of 8.9% during 2018-2023. Leukemia is a chronic disease that is prevalent across the globe and has been putting economic burden across the globe. It has a considerable presence in developed and developing economies such as US, UK, Spain, China, India and Korea. The market is expected to perform significantly due to advancements in leukemia therapeutics, R&D, funding from government and private players and successful clinical trials. The untapped APAC region is the most emerging market growing at the highest CAGR during the forecast period. However, the high cost of leukemia therapeutic and less awareness among key regions is a concern for the growth of the leukemia therapeutics market in emerging economies. The diagnosis of leukemia includes health and physical exam, Complete Blood Count, Biopsy and Bone Marrow Aspiration, Blood Chemistry Test, Cytochemistry, CT scan, X-ray, MRI, Ultrasound and so on. Leukemia is the growing market the key therapies of leukemia therapeutics include chemotherapy, stem cell transplant, radiation therapy, targeted therapy, watchful waiting and supportive therapy

The regional outlook of global leukemia therapeutics market includes: North America, Europe, APAC, and the Rest of the world. North America is further analyzed as the US and Canada; Europe as the UK, Germany, Italy, Spain, and ROE; and APAC as India, China, Japan, and ROAPAC. North America and Europe generates the highest revenues across the globe due to the huge number of leukemia patients and the highest rate of healthcare spending. APAC region such as China, India, Japan, and Korea are predicted to offer a variety of opportunities for the leukemia market due to improved healthcare spending, infrastructure, and favorable government policies.

Leukemia market players that are profiled in the report include Clavis Pharma ASA, Pfizer, Ambit, Novartis, Bristol, Genzyme, Celgene Cephalon and Innate Pharma. The leukemia market has a huge opportunity for new entrants and established players since the FDA nod to recent leukemia drugs created massive demand for leukemia drugs. Leukemia market players have significant investment in R&D programs across the globe. The successful clinical trials of leukemia drugs are expected to get FDA approval in the near future. The report also covers various factors that influence the market, for example, the government regulations, drug and device laws and regulations, regulations on clinical trials and government policies are also covered at length. The report also covers the type of Leukemia diagnosis, types and therapies extensively with the latest update on pipeline products in pipeline analysis.

Research methods and tools

The market study of leukemia therapeutics has been incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary sources include

Financial/annual reports of companies involved in the market

Forward-looking statement of key leukemia therapeutics market players

Authentic Public Databases

Whitepapers, research-papers and news blogs

Company websites and their product catalogue.

The report is intended for global leukemia therapeutics market players, potential entrants, diagnostic laboratories, healthcare provider, universities for overall market insights. The report provides in-depth analysis on pricing, market size, market determinants and competitive landscape. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis delivering insights into the market for better business decisions.

The Report covers